Though Altman said he likely wouldn’t agree with Trump on “everything,” the OpenAI CEO said he believes “he will be incredible for the country in many ways.”

Sam Altman, the CEO of OpenAI, has announced a shift in his previously critical perspective on President Donald Trump. Newsweek has contacted OpenAI and the White House for comment via email.

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin studies this year.

Sam Altman's comments came amid a flurry of online exchanges between himself, Musk, and Microsoft over the $500 billion Stargate Project announced by Trump.

Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT reports.

OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI agent that can act

Cathie Wood and her Ark Invest funds sold Oklo — the nuclear power startup backed by OpenAI head Sam Altman — and purchased uranium refiner Cameco on Tuesday ahead of President Donald Trump's announcement of a private sector investment of up to $500 billion to fund infrastructure for artificial intelligence.

Tensions between technology leaders Elon Musk and OpenAI CEO Sam Altman were on full display this week after the Tesla CEO slammed the new artificial intelligence (AI) infrastructure project,

ChatGPT became inaccessible for millions of users worldwide, showing a 'bad gateway error'. OpenAI promptly issued a fix.

Some of the billionaire tech CEOs who now support Trump also seem to have adopted parts of his personality. Sooner or later, the politicians who most admire Donald Trump begin to emulate him. They adopt his populist rhetoric,

Elon Musk's criticism of President Trump's $500 billion Stargate AI initiative has sparked outrage among White House aides.